NYSEArca - Nasdaq Real Time Price USD

SPDR?S&P?Biotech ETF (XBI)

101.26 +0.35 (+0.35%)
At close: August 30 at 4:00 PM EDT
101.45 +0.19 (+0.19%)
After hours: August 30 at 7:59 PM EDT
Loading Chart for XBI
DELL
  • Previous Close 100.91
  • Open 101.27
  • Bid 101.41 x 800
  • Ask 101.66 x 800
  • Day's Range 99.85 - 101.86
  • 52 Week Range 63.80 - 103.52
  • Volume 5,275,178
  • Avg. Volume 7,862,920
  • Net Assets 7.81B
  • NAV 101.34
  • PE Ratio (TTM) --
  • Yield 0.13%
  • YTD Daily Total Return 13.54%
  • Beta (5Y Monthly) 0.98
  • Expense Ratio (net) 0.35%

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

SPDR State Street Global Advisors

Fund Family

Health

Fund Category

7.81B

Net Assets

2006-01-31

Inception Date

Performance Overview: XBI

View More

Trailing returns as of 8/31/2024. Category is Health.

YTD Return

XBI
13.54%
Category
8.41%
?

1-Year Return

XBI
28.03%
Category
8.74%
?

3-Year Return

XBI
8.61%
Category
2.12%
?

People Also Watch

Holdings: XBI

View More

Top 10 Holdings (27.24% of Total Assets)

SymbolCompany% Assets
GILD
Gilead Sciences, Inc. 2.95%
AMGN
Amgen Inc. 2.81%
SRPT
Sarepta Therapeutics, Inc. 2.79%
ABBV
AbbVie Inc. 2.77%
EXAS
Exact Sciences Corporation 2.75%
UTHR
United Therapeutics Corporation 2.74%
REGN
Regeneron Pharmaceuticals, Inc. 2.62%
ALNY
Alnylam Pharmaceuticals, Inc. 2.62%
VKTX
Viking Therapeutics, Inc. 2.60%
VRTX
Vertex Pharmaceuticals Incorporated 2.60%

Sector Weightings

Recent News: XBI

View More

Research Reports: XBI

View More

Related Tickers